| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/02/2002 | EP1201767A2 Method of analyzing double stranded DNA |
| 05/02/2002 | EP1201766A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 05/02/2002 | EP1201765A2 Cellular kinases involved in cytomegalovirus infection and their inhibition |
| 05/02/2002 | EP1201764A2 Assays for identifying phosphatase inhibitors |
| 05/02/2002 | EP1201753A1 Methods for the analysis of non-proteinaceous components using a protease from a bacillus strain |
| 05/02/2002 | EP1201752A1 Methods for the analysis of non-proteinaceous components using a protease from a Bacillus strain |
| 05/02/2002 | EP1201751A1 Method for selecting highly functional nucleic acid molecules within cells |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1201305A2 Microfluidic reaction and transfer system |
| 05/02/2002 | EP1201304A2 Microstructured platform for examining a liquid |
| 05/02/2002 | EP1201255A2 Biological indicator for sterilization processes with double buffer system |
| 05/02/2002 | EP1200836A1 Method for controlling the quality of the endothelium lining of natural blood vessels prostheses |
| 05/02/2002 | EP1200834A1 Method for screening molecules for the treatment of huntington disease |
| 05/02/2002 | EP1200833A1 Difference detection methods using matched multiple dyes |
| 05/02/2002 | EP1200831A1 Modulating binding site on potassium channels used for screening |
| 05/02/2002 | EP1200829A2 Nmr rapid identification of bi-ligand drug candidates |
| 05/02/2002 | EP1200828A2 Methods of diagnosing and treating irritable bowel syndrome and other disorders |
| 05/02/2002 | EP1200823A1 A sensor comprising a hydrophilic matrix material |
| 05/02/2002 | EP1200821A1 Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility |
| 05/02/2002 | EP1200820A2 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 05/02/2002 | EP1200812A2 Hydrogen peroxide monitoring |
| 05/02/2002 | EP1200631A2 Nucleic acids for detecting parvovirus and methods of using same |
| 05/02/2002 | EP1200630A1 Biochemical sensor system with increased sensitivity by molecular amplification of the signal |
| 05/02/2002 | EP1200629A2 Identification of genetic markers of biological age and metabolism |
| 05/02/2002 | EP1200627A1 Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
| 05/02/2002 | EP1200626A1 Method for amplification of nucleic acids |
| 05/02/2002 | EP1200625A1 Methods for determining the specificity and sensitivity of oligonucleotides for hybridization |
| 05/02/2002 | EP1200624A2 Multiplexed strand displacement for nucleic acid determinations |
| 05/02/2002 | EP1200623A2 Diagnostic method comprising wt1 sequences |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |
| 05/02/2002 | EP1200621A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 05/02/2002 | EP1200620A2 Process for removing systematic error and outlier data and for estimating random error in chemical and biological assays |
| 05/02/2002 | EP1200619A1 Computer-assisted formulation of culture media |
| 05/02/2002 | EP1200618A2 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200599A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200592A2 Mammalian cytokines; related reagents |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200577A2 In vitro selection and optional identification of polypeptides using solid support carriers |
| 05/02/2002 | EP1200571A1 Secretory molecules |
| 05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
| 05/02/2002 | EP1200565A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 05/02/2002 | EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
| 05/02/2002 | EP1200475A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 05/02/2002 | EP1200472A1 Odorant receptors |
| 05/02/2002 | EP1200470A2 Globular assembly of amyloid beta protein and uses thereof |
| 05/02/2002 | EP1200467A1 Novel human calcium sensitive potassium channel subunits |
| 05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| 05/02/2002 | EP1200458A1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 05/02/2002 | EP1200456A1 Antisense modulation of pten expression |
| 05/02/2002 | EP1200455A1 Enzyme catalyzed therapeutic activation |
| 05/02/2002 | EP1200191A1 Low volume chemical and biochemical reaction system |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200130A2 Methods for treating therapy-resistant tumors |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/02/2002 | EP1200113A2 Reagents and methods useful for detecting diseases of the prostate |
| 05/02/2002 | EP1200080A1 Assay for d-serine transport antagonist and use for treating psychosis |
| 05/02/2002 | EP1200078A1 Compositions and methods for promoting nerve regeneration |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | EP1123411A4 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with diseases |
| 05/02/2002 | EP1036202B1 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
| 05/02/2002 | EP0929694A4 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 05/02/2002 | EP0739420B1 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of clostridium perfringens and their application to the detection and counting of these bacteriae |
| 05/02/2002 | EP0713534B1 Immunoassay procedure utilizing fluorogenic tracer antigens |
| 05/02/2002 | EP0683822B1 Preparation of photoprotein conjugates and methods of use thereof |
| 05/02/2002 | EP0654972B1 Method and apparatus for obtaining cytology monolayers |
| 05/02/2002 | EP0573500B2 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 05/02/2002 | EP0455665B1 Hybrid seed production |
| 05/02/2002 | DE10052583A1 Devising optimal strategy for diagnosis of microtissue arrays, useful e.g. for detecting tumor-related genomic abnormalities, by computer modeling of cell nuclei |
| 05/02/2002 | DE10051714A1 Controlling performance of complex polymerase chain reaction amplification, useful e.g. for genotyping, using a set of many specific primers and non-specific counter-strand primers |
| 05/02/2002 | DE10051174A1 Detecting Staphylococcus by nucleic acid amplification, useful for testing e.g. clinical samples, can identify simultaneously enterotoxin and methicillin-resistance genes |
| 05/02/2002 | DE10049587A1 Vektorsystem für Pflanzen Vector system for plants |
| 05/02/2002 | CA2428907A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | CA2427297A1 A reagent and kit for determining global coagulability and hemostatic potential |
| 05/02/2002 | CA2427231A1 Method of determining global coagulability and hemostatic potential |
| 05/02/2002 | CA2427109A1 In vitro selection of signaling aptamers |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2426896A1 Compositions and methods for the discovery and selection of biological information |
| 05/02/2002 | CA2426812A1 Detecting specific nucleotide sequences |
| 05/02/2002 | CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | CA2426744A1 Method for in vivo identification of intracellular epitopes |
| 05/02/2002 | CA2426465A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | CA2426321A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |